NTU Singapore to embark on research to tackle ageing-related joint condition with S$1.2 million gift from StemiGen Therapeutics (IMAGE)

Nanyang Technological University

NTU Singapore to embark on research to tackle ageing-related joint condition with S$1.2 million gift from StemiGen Therapeutics

Caption

(L-R, foreground) The S$1.2 million gift to NTU was formalised at a signing ceremony today between Dr James Hsieh, CEO, StemiGen Therapeutics and Ms Lien Siaou-Sze, NTU Vice President, University Advancement, which was witnessed by (L-R, background) Mr Steven Lim, Chairman, StemiGen Therapeutics, Guest-of-Honour, Prof Benjamin Seet, Deputy Group CEO (Education & Research) of the National Healthcare Group and Prof Joseph Sung, LKCMedicine's Dean and NTU Senior Vice President (Health and Life Sciences).

Credit

StemiGen Therapeutics

Usage Restrictions

N.A.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.